Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy.

De-Zhen Guo,Shi-Yu Zhang,San-Yuan Dong,Jia-Yan Yan,Yu-Peng Wang,Ya Cao,Sheng-Xiang Rao,Jia Fan,Xin-Rong Yang,Ao Huang,Jian Zhou

Frontiers in immunology（2023）

引用 0|浏览35

暂无评分

摘要

The PIMET score comprising metastasis and PIVKA-II could serve as a helpful prognostic model for uHCC receiving lenvatinib monotherapy or lenvatinib plus ICI. The PIMET score could guide the treatment decision and facilitate precision medicine for uHCC patients.

查看译文

关键词

immunotherapy,lenvatinib,liver cancer,predicting model,protein induced by vitamin K absence or antagonist-II

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要